Literature DB >> 15000492

Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis.

Ming-Ping Wu1, Ching-Cherng Tzeng, Li-Wha Wu, Kuo-Feng Huang, Cheng-Yang Chou.   

Abstract

PURPOSE: The acquisition of an angiogenic phenotype (angiogenic switch) is essential for cervical carcinogenesis. This study was aimed to examine the spatial and temporal relationship of thrombospondin-1 (TSP-1) expression in patients with precursor lesions and squamous cell carcinoma of uterine cervix and to correlate its expression with tumor angiogenesis. PATIENTS AND METHODS: TSP-1 expression and microvessel density were assessed by immunohistochemistry in samples obtained from patients with pathological diagnoses of cervical intraepithelial neoplasm I, carcinoma in situ, invasive squamous cell carcinoma (SCC), and benign disease (N = 12 from each group). Two representative blocks that contained serial changes of cervical lesions from these 48 subjects were examined, and the pathological findings were categorized into the four groups of (1) normal cervical epithelia, (2) low-grade squamous intraepithelial lesions (LSILs), (3) high-grade SILs (HSILs), and (4) SCC.
RESULTS: A total of 120 foci with various cervical lesions from 98 slides were examined and classified into normal (48), LSIL (36), HSIL (24), and SCC epithelium (12). Immunohistochemical studies showed that TSP-1 was mainly localized at the basal epithelial cells, and we named it as the "TSP-1 fence." The mean microvessel density counts and TSP-1 scores for normal, LSIL, HSIL, and SCC epithelium were 7.3 +/- 2.9, 9.9 +/- 3.4, 17.7 +/- 5.1, and 22.8 +/- 8.6, and 3.8 +/- 0.4, 3.8 +/- 0.4, 1.8 +/- 0.4, and 1.5 +/- 0.5, respectively. The TSP-1 intensities were significantly higher and the MVD counts lower in the groups of normal and LSIL epithelium than in those with HSIL and SCC epithelium. In addition, microvessel density count was negatively associated with the intensity of TSP-1. DISCUSSION: Our results indicate that the disruption of TSP-1 fence and the switch to angiogenic phenotype occurred during the transition from LSIL into HSIL. This concordance suggests that TSP-1 plays a role in the regulation of angiogenic switch. We conclude thatthe onset of angiogenesis is an early event in cervical carcinogenesis due, in part, to the down-regulation of TSP-1 by the dysplastic epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000492     DOI: 10.1097/00130404-200401000-00007

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  10 in total

Review 1.  Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.

Authors:  Charles R Wira; Mickey V Patel; Mimi Ghosh; Lucy Mukura; John V Fahey
Journal:  Am J Reprod Immunol       Date:  2011-03       Impact factor: 3.886

Review 2.  Exploring the therapeutic rationale for angiogenesis blockade in cervical cancer.

Authors:  Lauren S Krill; Krishnansu S Tewari
Journal:  Clin Ther       Date:  2015-01-01       Impact factor: 3.393

Review 3.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

Review 4.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29

5.  Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.

Authors:  Leslie M Randall; Bradley J Monk; Kathleen M Darcy; Chunqiao Tian; Robert A Burger; Shu-Yuan Liao; William A Peters; Richard J Stock; John P Fruehauf
Journal:  Gynecol Oncol       Date:  2008-12-24       Impact factor: 5.482

Review 6.  Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Int J Mol Sci       Date:  2013-06-07       Impact factor: 5.923

Review 7.  Angiogenesis and antiangiogenic agents in cervical cancer.

Authors:  Federica Tomao; Anselmo Papa; Luigi Rossi; Eleonora Zaccarelli; Davide Caruso; Federica Zoratto; Pierluigi Benedetti Panici; Silverio Tomao
Journal:  Onco Targets Ther       Date:  2014-12-03       Impact factor: 4.147

8.  Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers.

Authors:  M K Maw; J Fujimoto; T Tamaya
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

9.  Stromal fibroblast activation and their potential association with uterine fibroids (Review).

Authors:  Li-Hua Zheng; Feng-Feng Cai; Isabell Ge; Ewelina Biskup; Zhong-Ping Cheng
Journal:  Oncol Lett       Date:  2014-06-04       Impact factor: 2.967

10.  Dysregulation of Stemness Pathways in HPV Mediated Cervical Malignant Transformation Identifies Potential Oncotherapy Targets.

Authors:  Megha Budhwani; Samuel W Lukowski; Sandro V Porceddu; Ian H Frazer; Janin Chandra
Journal:  Front Cell Infect Microbiol       Date:  2020-06-25       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.